Key Highlights

● HeartCore shareholders re-elected all five director nominees to one-year terms at the September 25, 2026 annual meeting.

● Shareholders ratified MaloneBailey, LLP as HeartCore's independent registered public accounting firm for fiscal 2026.

● Every director nominee received zero votes against, indicating an uncontested election with no dissident slate.

● The auditor ratification passed with 839,950 votes in favor versus 59,411 against, about 7% opposition.

HeartCore Enterprises (NASDAQ:HTCR), a Nasdaq-listed company, disclosed in an 8-K that shareholders at its 2026 annual meeting on September 25, 2026 re-elected all five of the company's director nominees and ratified MaloneBailey, LLP as its independent registered public accounting firm for fiscal 2026.

The Director Election

The filing, made under Item 5.07, Submission of Matters to a Vote of Security Holders, and Item 9.01, Financial Statements and Exhibits, shows all five director nominees were elected to serve, per the filing, "for a term of one year, until the next annual meeting of stockholders." The five directors elected were Sumitaka Yamamoto, Ferdinand Groenewald, Kimio Hosaka, Yoonji Lee, and Koji Sato. Each nominee received identical broker non-vote totals of 331,879 and zero votes against, with Yamamoto receiving the highest favorable tally at 558,404 votes and Groenewald the lowest at 557,300, while abstentions across the five nominees ranged from 10,438 to 11,542.

The Auditor Ratification

Shareholders separately ratified MaloneBailey, LLP as HeartCore's independent registered public accounting firm for fiscal year 2026. That proposal passed with 839,950 votes in favor, 59,411 against, and 1,360 abstentions, with no broker non-votes recorded for the auditor matter, reflecting that auditor ratification is typically treated as a routine matter on which Brokers holding shares in street name may vote without specific instructions from beneficial owners, unlike director elections. The higher total vote count on the auditor proposal compared with the roughly 900,000 votes cast in the director elections is consistent with that difference in broker voting treatment, since routine matters can draw in additional shares voted by brokers exercising discretionary authority.

Why Annual Meeting Votes Matter

Annual meeting votes on director elections and auditor ratification are standard corporate governance events required of essentially all public companies, giving shareholders their primary formal mechanism to weigh in on board composition and the integrity of the company's financial reporting oversight. Unanimous slates with zero votes against any individual director, as occurred here, generally indicate an uncontested election in which no dissident Shareholder group ran a competing slate or withheld support in an organized fashion. The auditor ratification vote, while it received some opposition, still passed comfortably, with the 59,411 votes against representing roughly 7% of the votes cast on that proposal.

The 8-K does not include a description of HeartCore's Business operations, its financial results, or any other matters discussed at the meeting beyond the two votes reported.

What the Filing Does Not Say

The filing does not disclose whether any other business was conducted at the annual meeting beyond the director election and auditor ratification, and it does not provide the total number of shares outstanding or represented at the meeting, information that would allow for a fuller assessment of shareholder participation. It also does not identify any specific committee assignments the newly elected directors will hold, and it does not describe HeartCore's business operations, financial results, or any strategic initiatives underway at the company.

Looking Toward Fiscal 2026 Reporting

With directors serving one-year terms, investors should expect HeartCore's next annual meeting and director election to occur around September 2027, and should watch the company's subsequent periodic filings for its fiscal 2026 financial results now that MaloneBailey has been formally ratified to audit them. Because this 8-K covers only the procedural results of the vote, any operational or strategic news from HeartCore during the same period would appear in separate filings rather than as part of this annual meeting disclosure.